Brief: CK Life Sciences Intl (Holdings) Says HY Profit Attributable HK$87.4 Mln
Aug 4 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* HY PROFIT ATTRIBUTABLE HK$87.4 MILLION VERSUS HK$171.3
MILLION
* HY REVENUE HK$2.38 BILLION VERSUS HK$2.60 BILLION
Source text https://bit.ly/39UkKme
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development